{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:06:20Z","timestamp":1790726780856,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.coph.2023.102363","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T18:23:46Z","timestamp":1679509426000},"page":"102363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Targeting the altered duodenal microenvironment in functional dyspepsia"],"prefix":"10.1016","volume":"70","author":[{"given":"Matthias","family":"Ceulemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-0903","authenticated-orcid":false,"given":"Tim","family":"Vanuytsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2023.102363_sref1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/13543784.2019.1673365","article-title":"Drugs under development for the treatment of functional dyspepsia and related disorders","volume":"28","author":"Tack","year":"2019","journal-title":"Expet Opin Invest Drugs"},{"key":"10.1016\/j.coph.2023.102363_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/apt.12355","article-title":"Functional dyspepsia: the economic impact to patients","volume":"38","author":"Lacy","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_bib4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/apt.13738","article-title":"Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study","volume":"44","author":"Koloski","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders: disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/gutjnl-2019-318536","article-title":"Novel concepts in the pathophysiology and treatment of functional dyspepsia","volume":"69","author":"Wauters","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_sref9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41395-018-0258-6","article-title":"Prokinetics for functional dyspepsia: a systematic review and meta-analysis of randomized control trials","volume":"114","author":"Pittayanon","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib10","article-title":"Micro-inflammation in functional dyspepsia: a systematic review and meta-analysis","volume":"30","author":"Du","year":"2018","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.coph.2023.102363_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413609","article-title":"Duodenal dysbiosis and relation to the efficacy of proton pump inhibitors in functional dyspepsia","volume":"22","author":"Wauters","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2023.102363_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.831761","article-title":"Immune activation in functional dyspepsia: bystander becoming the suspect","volume":"16","author":"Ceulemans","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.coph.2023.102363_bib13","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","article-title":"Role of impaired gastric accommodation to a meal in functional dyspepsia","volume":"115","author":"Tack","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib14","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1023\/A:1018803129779","article-title":"Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis","volume":"43","author":"Quartero","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2023.102363_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/gast.2001.27180","article-title":"Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia","volume":"121","author":"Tack","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ajg.2016.499","article-title":"Pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome III criteria","volume":"112","author":"Vanheel","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-018-0038-z","article-title":"Gastroparesis","volume":"4","author":"Camilleri","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.coph.2023.102363_bib18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gutjnl-2018-316405","article-title":"Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis","volume":"68","author":"Vijayvargiya","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_sref19","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1053\/j.gastro.2021.01.230","article-title":"Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features","volume":"160","author":"Pasricha","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib20","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2013.118","article-title":"The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis","volume":"108","author":"Janssen","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cgh.2021.10.038","article-title":"AGA clinical practice update on management of medically refractory gastroparesis: expert review","volume":"20","author":"Lacy","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2023.102363_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ueg2.12060","article-title":"United European gastroenterology (UEG) and European society for neurogastroenterology and motility (ESNM) consensus on gastroparesis","volume":"9","author":"Schol","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.coph.2023.102363_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nrgastro.2012.255","article-title":"Changes in gastrointestinal tract function and structure in functional dyspepsia","volume":"10","author":"Vanheel","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2023.102363_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.48.3.347","article-title":"Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia","volume":"48","author":"Feinle","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCG.0b013e31818e37ab","article-title":"Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system","volume":"43","author":"Bratten","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cgh.2007.05.015","article-title":"Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study","volume":"5","author":"Talley","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2023.102363_sref27","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.cgh.2022.01.014","article-title":"Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies","volume":"20","author":"Shah","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2023.102363_bib28","article-title":"Novel robust method for eosinophil counting in duodenal biopsy sections","volume":"10","author":"Ceulemans","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.coph.2023.102363_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep34305","article-title":"Increased duodenal eosinophil degranulation in patients with functional dyspepsia: a prospective study","volume":"6","author":"Du","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2023.102363_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.anndiagpath.2015.02.001","article-title":"Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia","volume":"19","author":"Wang","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.coph.2023.102363_bib31","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1038\/s41598-018-23620-y","article-title":"Activation of eosinophils and mast cells in functional dyspepsia: an ultrastructural evaluation","volume":"8","author":"Vanheel","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2023.102363_bib32","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1152\/ajpgi.00015.2005","article-title":"Eosinophils alter colonic epithelial barrier function: role for major basic protein","volume":"289","author":"Furuta","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2023.102363_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041109","article-title":"Mechanisms of food-induced symptom induction and dietary management in functional dyspepsia","volume":"13","author":"Duncanson","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.coph.2023.102363_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.coph.2023.102363_bib35","first-page":"L1096","article-title":"Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons","volume":"273","author":"Garland","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.coph.2023.102363_bib36","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1172\/JCI116331","article-title":"Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor","volume":"91","author":"Jacoby","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2023.102363_bib37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ajg.2015.158","article-title":"Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia","volume":"110","author":"Cirillo","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5056\/jnm18176","article-title":"Degranulated eosinophils contain more fine nerve fibers in the duodenal mucosa of patients with functional dyspepsia","volume":"25","author":"Lee","year":"2019","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2023.102363_sref39","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.14309\/ajg.0000000000000827","article-title":"Evidence of duodenal epithelial barrier impairment and increased pyroptosis in patients with functional dyspepsia on confocal laser endomicroscopy and \"ex\u00a0vivo\" mucosa analysis","volume":"115","author":"Nojkov","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib40","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1038\/ctg.2017.12","article-title":"Endoscopy-guided evaluation of duodenal mucosal permeability in functional dyspepsia","volume":"8","author":"Ishigami","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/gutjnl-2012-303857","article-title":"Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia","volume":"63","author":"Vanheel","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_sref42","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1053\/j.gastro.2020.12.016","article-title":"Proton pump inhibitors reduce duodenal eosinophilia, mast cells and permeability in patients with functional dyspepsia","volume":"160","author":"Wauters","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/PSY.0000000000001012","article-title":"The interplay between stress and fullness in patients with functional dyspepsia and healthy controls: an exploratory experience sampling method study","volume":"84","author":"Klaassen","year":"2022","journal-title":"Psychosom Med"},{"key":"10.1016\/j.coph.2023.102363_bib44","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/gut.2009.181701","article-title":"Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine","volume":"58","author":"Zheng","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib45","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2036.2010.04282.x","article-title":"Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia","volume":"31","author":"Walker","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_bib46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/apt.15120","article-title":"Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress","volume":"49","author":"Koloski","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_bib47","article-title":"Duodenum at a crossroads: key integrator of overlapping and psychological symptoms in functional dyspepsia?","volume":"33","author":"Wauters","year":"2021","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.coph.2023.102363_bib48","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.cgh.2016.12.032","article-title":"Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population","volume":"15","author":"Jones","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2023.102363_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.gastro.2009.03.039","article-title":"Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study","volume":"137","author":"Aro","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib50","article-title":"Duodenal eosinophilia and the link to anxiety: a population-based endoscopic study","volume":"33","author":"Ronkainen","year":"2021","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.coph.2023.102363_bib51","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/gutjnl-2013-305690","article-title":"Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism","volume":"63","author":"Vanuytsel","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","article-title":"Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome","volume":"152","author":"Tap","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coph.2023.102363_bib54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000511944","article-title":"High prevalence of small intestinal bacterial overgrowth among functional dyspepsia patients","volume":"39","author":"Tziatzios","year":"2021","journal-title":"Dig Dis"},{"key":"10.1016\/j.coph.2023.102363_bib55","doi-asserted-by":"crossref","first-page":"935","DOI":"10.14309\/ajg.0000000000001197","article-title":"Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis","volume":"116","author":"Gurusamy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2016-000109","article-title":"Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt","volume":"3","author":"Nakae","year":"2016","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib57","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/gutjnl-2016-312574","article-title":"Dyspepsia and the microbiome: time to focus on the small intestine","volume":"66","author":"Zhong","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_sref58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000504090","article-title":"Higher levels of Streptococcus in upper gastrointestinal mucosa associated with symptoms in patients with functional dyspepsia","volume":"101","author":"Fukui","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.coph.2023.102363_sref59","article-title":"Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia","author":"Shanahan","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib60","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG clinical guideline: management of dyspepsia","volume":"112","author":"Moayyedi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_sref61","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2021-326583","article-title":"Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis","author":"Ford","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib62","article-title":"United European gastroenterology (UEG) and European society for neurogastroenterology and motility (ESNM) consensus on functional dyspepsia","volume":"33","author":"Wauters","year":"2021","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.coph.2023.102363_bib63","first-page":"Cd011194","article-title":"Proton pump inhibitors for functional dyspepsia","volume":"11","author":"Pinto-Sanchez","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2023.102363_bib64","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1038\/ctg.2015.20","article-title":"Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract","volume":"6","author":"Tsuda","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib65","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib66","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib67","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib68","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib69","series-title":"Pharmacological interventions for non-ulcer dyspepsia","author":"Moayyedi","year":"2006"},{"key":"10.1016\/j.coph.2023.102363_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/br.2016.828","article-title":"Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia","volume":"6","author":"Asaoka","year":"2017","journal-title":"Biomed Rep"},{"key":"10.1016\/j.coph.2023.102363_bib71","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00535-021-01843-7","article-title":"Evidence-based clinical practice guidelines for functional dyspepsia 2021","volume":"57","author":"Miwa","year":"2022","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coph.2018.08.015","article-title":"New developments in the treatment of gastroparesis and functional dyspepsia","volume":"43","author":"Tack","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2023.102363_bib73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2036.2012.05011.x","article-title":"Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders","volume":"35","author":"Tack","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_bib74","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.1993.00410120051007","article-title":"The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders","volume":"153","author":"Ganzini","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.coph.2023.102363_bib75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MCG.0000000000000543","article-title":"Domperidone is commonly prescribed with QT-interacting drugs: review of a community-based practice and a postmarketing adverse drug event reporting database","volume":"51","author":"Ehrenpreis","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12876-017-0639-0","article-title":"Prokinetics for the treatment of functional dyspepsia: bayesian network meta-analysis","volume":"17","author":"Yang","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gutjnl-2016-312361","article-title":"Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts","volume":"67","author":"Simr\u00e9n","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib78","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report","volume":"154","author":"Drossman","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.16072","article-title":"Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia","volume":"53","author":"Ford","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_bib80","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clpt.2003.09.019","article-title":"Cyclic antidepressants and the risk of sudden cardiac death","volume":"75","author":"Ray","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_bib81","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10620-020-06191-9","article-title":"Effects of low-dose amitriptyline on epigastric pain syndrome in functional dyspepsia patients","volume":"66","author":"Liu","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2023.102363_bib82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bpg.2017.09.006","article-title":"The role of smoking and alcohol behaviour in management of functional gastrointestinal disorders","volume":"31","author":"Ohlsson","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib83","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/jgh.15566","article-title":"Are psychological interventions effective in treating functional dyspepsia? A systematic review and meta-analysis","volume":"36","author":"Rodrigues","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2023.102363_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092693","article-title":"Diet and nutrients in gastrointestinal chronic diseases","volume":"12","author":"Corsello","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.coph.2023.102363_bib85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jgh.15694","article-title":"Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet versus traditional dietary advice for functional dyspepsia: a randomized controlled trial","volume":"37","author":"Goyal","year":"2022","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2023.102363_bib86","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5056\/jnm19005","article-title":"Non-pharmacological approach in the management of funcional dyspepsia","volume":"26","author":"Wang","year":"2019","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2023.102363_bib87","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/gutjnl-2018-316878","article-title":"Proton pump inhibitors and suppression of duodenal eosinophilia in functional dyspepsia","volume":"68","author":"Potter","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib88","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1053\/j.gastro.2021.02.016","article-title":"In esophageal squamous cells from eosinophilic esophagitis patients, Th2 cytokines increase eotaxin-3 secretion through effects on intracellular calcium and a non-gastric proton pump","volume":"160","author":"Odiase","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib89","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-230X-9-32","article-title":"Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics","volume":"9","author":"Friesen","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/000992280604500205","article-title":"Mucosal eosinophilia and response to H1\/H2 antagonist and cromolyn therapy in pediatric dyspepsia","volume":"45","author":"Friesen","year":"2006","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.coph.2023.102363_bib91","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/gutjnl-2019-318412","article-title":"Dual histamine blockade for the treatment of adult functional dyspepsia: a single centre experience","volume":"69","author":"Potter","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.coph.2023.102363_bib92","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/apt.16396","article-title":"Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trial","volume":"53","author":"Talley","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_sref93","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.coph.2023.102363_bib94","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2023.102363_bib96","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4168\/aair.2017.9.4.360","article-title":"CCR3 monoclonal antibody inhibits eosinophilic inflammation and mucosal injury in a mouse model of eosinophilic gastroenteritis","volume":"9","author":"Song","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.coph.2023.102363_bib97","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/cea.13217","article-title":"The JAK1\/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release","volume":"48","author":"Hermans","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2023.102363_bib98","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/iid3.397","article-title":"Ruxolitinib inhibits poly(I:C) and type 2 cytokines-induced CCL5 production in bronchial epithelial cells: a potential therapeutic agent for severe eosinophilic asthma","volume":"9","author":"Sada","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.coph.2023.102363_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111030","article-title":"The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis","volume":"9","author":"Dang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2023.102363_bib100","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7490452","article-title":"Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-associated dyspepsia: a multicenter randomized double-blind controlled trial","volume":"2016","author":"Takagi","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.coph.2023.102363_bib101","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000479000","article-title":"The ameliorating effect of Lactobacillus gasseri OLL2716 on functional dyspepsia in Helicobacter pylori-uninfected individuals: a randomized controlled study","volume":"96","author":"Ohtsu","year":"2017","journal-title":"Digestion"},{"key":"10.1016\/j.coph.2023.102363_bib102","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000144","article-title":"Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia","volume":"4","author":"Igarashi","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.coph.2023.102363_bib103","article-title":"Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies","volume":"49","author":"Drago","year":"2021","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.coph.2023.102363_sref104","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S2468-1253(21)00226-0","article-title":"Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial","volume":"6","author":"Wauters","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2023.102363_bib105","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apt.13945","article-title":"Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia","volume":"45","author":"Tan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2023.102363_bib106","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N\u00a0Engl J Med"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:58:04Z","timestamp":1761461884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489223000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":106,"alternative-id":["S1471489223000164"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2023.102363","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the altered duodenal microenvironment in functional dyspepsia","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2023.102363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102363"}}